Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears
NCT: NCT05444465 · RECRUITING
Brief Summary
The purpose of the study is to assess whether the REGENETEN™ Bioinductive Implant allows patients to get back to their everyday activities quicker than if the tendon is repaired by the standard repair technique 'Completion and Repair' for surgically treating partial-thickness rotator cuff tears.
Frequently Asked Questions
What is Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears?
Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears is a clinical trial registered under NCT05444465. Current status: RECRUITING.
What is the status of NCT05444465?
The current status of NCT05444465 (Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears) is: RECRUITING.
When did Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears start?
Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears started on 2022-08-30.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.